Optimising SARS-CoV-2 vaccination schedules
Lancet
.
2021 Sep 4;398(10303):819-821.
doi: 10.1016/S0140-6736(21)01729-3.
Epub 2021 Aug 6.
Author
Cristobal Belda-Iniesta
1
Affiliation
1
Instituto de Salud Carlos III, Madrid 28029, Spain. Electronic address: cbelda@isciii.es.
PMID:
34370969
PMCID:
PMC8346239
DOI:
10.1016/S0140-6736(21)01729-3
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2*
Vaccination
Substances
COVID-19 Vaccines